ePharmacies

ePharmacies

Global ePharmacies Market to Reach US$222.8 Billion by 2030

The global market for ePharmacies estimated at US$84.7 Billion in the year 2023, is expected to reach US$222.8 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2023-2030. Over-The-Counter (OTC) Drugs, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$123.3 Billion by the end of the analysis period. Growth in the Prescription Drugs segment is estimated at 16.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.7 Billion While China is Forecast to Grow at 20.2% CAGR

The ePharmacies market in the U.S. is estimated at US$29.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$34.0 Billion by the year 2030 trailing a CAGR of 20.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 13.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.4% CAGR.

Global ePharmacies Market - Key Trends and Drivers Summarized

E-pharmacies, or online pharmacies, have dramatically transformed the pharmaceutical landscape by leveraging the rise of internet technology to deliver medications directly to consumers. This transition to digital platforms offers unprecedented convenience, eliminating the need for physical visits to pharmacies and enabling prescriptions to be processed and delivered through a seamless, contact-free online system. Utilizing e-prescribing systems, doctors can send prescriptions directly to pharmacies, where medications are selected, paid for online, and delivered via mail or courier services. This model not only meets modern health-conscious demands by minimizing physical interactions but also reduces overhead costs for e-pharmacies, allowing them to offer medications at lower prices than traditional brick-and-mortar locations. Additionally, the online model supports privacy and reduces the risk of human error, enhancing patient safety and providing customers with comprehensive medication information, thereby increasing transparency and consumer education.

The growth of e-pharmacies is significantly influenced by their integration with broader health technology systems, such as electronic health records (EHRs) and advanced data analytics. These integrations streamline the prescription to delivery pipeline, enhance operational efficiency, and allow for personalized marketing and efficient inventory management. Consumer trust has also shifted positively towards online transactions, encouraged by robust security measures and encryption technologies that protect sensitive health data. Moreover, the widespread adoption of mobile technology enables consumers to access e-pharmacy services on-the-go, further enhancing convenience. The expansion of telemedicine contributes to this growth, creating a direct link between virtual health consultations and immediate prescription fulfillment via online platforms. Increased health awareness among consumers who are keen on managing their health proactively also fuels the demand for e-pharmacies.

Regulatory support and evolving digital health policies are pivotal in facilitating the growth of e-pharmacies. Regulations allowing electronic prescriptions and the expansion of mail-order services within healthcare plans are critical enablers. Additionally, logistics and distribution innovations, including the potential use of drones for delivery, are set to improve the reliability and speed of pharmaceutical deliveries, supporting the operational model of e-pharmacies. These factors collectively underscore a shift towards more integrated and technologically advanced healthcare solutions, reflecting broader trends towards digitalization in response to changing consumer needs and the ongoing evolution of healthcare practices.

Select Competitors (Total 63 Featured) -
  • 1mg Technologies Pvt. Ltd.
  • Canada Drugs
  • DocMorris NV
  • Dr Fox Pharmacy
  • eDrugstore.com
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • InternationalDrugMart.com
  • MediSave
  • Netmeds Marketplace Limited
  • OptumRx, Inc.
  • PlanetRx
  • Rowlands Pharmacy
  • The Kroger Company
  • Walgreen Co.,
  • Wal-Mart Stores, Inc.
  • Zur Rose Group AG
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
What’s the Current State of Global Drug Distribution?
ePharmacies, an Emerging Link in the Distribution System with the Promise of Closing the Gap in Modern Healthcare
As Global Medicine Demand Breaches the Trillion Dollar Mark, ePharmacies Role in Enabling Better Access to Medicines is Poised to Grow Bigger: Global Medicine Spending (In US$ Billion) for the Years 2022, 2024, 2026, 2028 and 2030
Economic Frontiers: Trends, Trials & Transformations
In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
Competition
ePharmacies – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
ePharmacies: Overview & Types
Influencer/Product/Technology Insights
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Advanced Internet Infrastructure & Robust Smartphone Penetration Provide the Launchpad for the Rise of ePharmacies
Access to Internet Equals Access to e-Pharmacy Services: Global Internet Users (In Million) for Years 2018 through 2025
Smartphones Provide the Gateway to Access e-Pharmacies: Global Smartphones Users (In US$ Million) for Years 2024, 2026, 2028 and 2030
Improved Digital Payment Solutions Sustain Growth in e-Pharmacies
Enhanced Digital Payment Solutions Propel E-Pharmacy Sales to New Heights: Global Digital Payments Transaction Value (In US$ Trillion) for Years 2024, 2026, 2028, 2030, and 2032
Healthcare Challenges of an Aging Population Opens Opportunities for e-Pharmacies
E-Pharmacies Revolutionize Healthcare for Aging Populations, Enhancing Accessibility and Reducing Costs: Global Aging Population (Aged 65+ In Million) for Years 2024, 2040, 2050 and 2100
Rapid Evolution of Telemedicine Drives Demand Opportunities for e-Pharmacies Services
From Virtual Consultations to Doorstep Delivery, Telemedicine-E-Pharmacy Alliance is Poised to Score Big Gains in the Market: Global Telemedicine Market (In US$ Billion) for Years 2024, 2026, 2028, 2030 and 2032
New Opportunities Emerge With Seamless Integration of Telepharmacy With e-Pharmacies. Here’s the Story
Expanding Mobile Health Creates a Parallel Expansion of Opportunities for e-Pharmacies
Advanced mHealth Apps Spearhead the Progress and Integration of e-Pharmacy Apps: Global mHealth Apps Market (In US$ Billion) for Years 2024, 2026, 2028, 2030 and 2032
Rise in Chronic Diseases Expands the Addressable Market Opportunity for e-Pharmacies
As Disease Burden Rises so Does the Need for Medicines: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2024 and 2030
Growing Use of Medicines is a Clear Opportunity for e-Pharmacies to Tap Into: Global Use of Medicines (In Defined Daily Doses (DDD) in Billions) for the Years 2024, 2026 and 2028
Rise of AI in ePharmacies, an Exciting Trend to Watch Out For!
With Regulators Failing to keep Up, Illegal ePharmacies Cast a Shadow Over the Market
As Illegal Pharmacies Eat Away into Legal Markets & Push Up Healthcare Costs by Causing Adverse Health Events, the Need of the Hour is Strict Regulation & Control: Lost Economic Value to U.S. Healthcare Systems Due to Illegal Pharmacies (In US$ Billion) for Years 2020, 2022 and 2024
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World ePharmacies Market Analysis of Annual Sales in US$ Million for Years 2019 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 4: World 11-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2019, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Over-The-Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Over-The-Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 7: World 11-Year Perspective for Over-The-Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2019, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 10: World 11-Year Perspective for Prescription Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2019, 2024 & 2030
Recent Market Activity
III. MARKET ANALYSIS
UNITED STATES
TABLE 11: USA Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 12: USA Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 13: USA 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
CANADA
TABLE 14: Canada Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 15: Canada Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 16: Canada 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
JAPAN
TABLE 17: Japan Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 18: Japan Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 19: Japan 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
CHINA
TABLE 20: China Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: China Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 22: China 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
EUROPE
TABLE 23: Europe Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: Europe Historic Review for ePharmacies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 25: Europe 11-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2019, 2024 & 2030
TABLE 26: Europe Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Europe Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 28: Europe 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
FRANCE
TABLE 29: France Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: France Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 31: France 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
GERMANY
TABLE 32: Germany Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Germany Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 34: Germany 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
ITALY
TABLE 35: Italy Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Italy Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 37: Italy 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
UNITED KINGDOM
TABLE 38: UK Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: UK Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 40: UK 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
SPAIN
TABLE 41: Spain Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Spain Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 43: Spain 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
RUSSIA
TABLE 44: Russia Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Russia Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 46: Russia 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
REST OF EUROPE
TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Rest of Europe Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 49: Rest of Europe 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
ASIA-PACIFIC
TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 51: Asia-Pacific Historic Review for ePharmacies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 52: Asia-Pacific 11-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2019, 2024 & 2030
TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Asia-Pacific Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 55: Asia-Pacific 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
AUSTRALIA
TABLE 56: Australia Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Australia Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 58: Australia 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
INDIA
TABLE 59: India Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: India Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 61: India 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
SOUTH KOREA
TABLE 62: South Korea Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: South Korea Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 64: South Korea 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Rest of Asia-Pacific Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 67: Rest of Asia-Pacific 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
LATIN AMERICA
TABLE 68: Latin America Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Latin America Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 70: Latin America 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
MIDDLE EAST
TABLE 71: Middle East Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Middle East Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 73: Middle East 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
AFRICA
TABLE 74: Africa Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Africa Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
TABLE 76: Africa 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings